|Bid||228.90 x 800|
|Ask||230.68 x 800|
|Day's Range||227.54 - 231.11|
|52 Week Range||177.05 - 264.97|
|Beta (5Y Monthly)||0.82|
|PE Ratio (TTM)||18.71|
|Earnings Date||Oct 28, 2020|
|Forward Dividend & Yield||6.40 (2.77%)|
|Ex-Dividend Date||Aug 14, 2020|
|1y Target Est||260.79|
Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.60 per share dividend for the fourth quarter of 2020. The dividend will be paid on December 8, 2020, to all stockholders of record as of the close of business on November 16, 2020.
Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amgen stock has faded from a July high as it's not lately updated it two-pronged approach to coronavirus treatment, teaming with Adaptive Biotechnologies and testing Otezla. Is AMGN a buy?